U.S. Venture Partners (USVP), founded in 1981 and based in Menlo Park, California, is a venture capital firm that specializes in early-stage investments. The firm focuses on transformative ideas within the information technology and healthcare sectors, emphasizing innovation that drives economic growth and job creation. USVP's investment areas include enterprise software, IT security, consumer internet, mobile applications, e-commerce, healthcare, and IT-enabled healthcare services. The team at USVP comprises former entrepreneurs, technologists, corporate executives, financial professionals, and industry experts, all dedicated to supporting entrepreneurs in their journey to build impactful companies. The firm primarily targets businesses located on the West Coast of the United States, seeking opportunities in B2B, life sciences, oncology, cybersecurity, digital health, and cloud technology.
MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating neurological disorders. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation to address conditions such as tinnitus, chronic pain, and rehabilitation following strokes. Its flagship product, Vivistim, has received FDA approval for use in ischemic stroke survivors experiencing moderate to severe upper limb impairment. MicroTransponder's innovative approaches, which include paired vagus nerve stimulation and wireless neurostimulation systems, are designed to enhance recovery and improve quality of life for patients facing various neurological challenges.
MicroTransponder
Series E in 2022
MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating neurological disorders. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation to address conditions such as tinnitus, chronic pain, and rehabilitation following strokes. Its flagship product, Vivistim, has received FDA approval for use in ischemic stroke survivors experiencing moderate to severe upper limb impairment. MicroTransponder's innovative approaches, which include paired vagus nerve stimulation and wireless neurostimulation systems, are designed to enhance recovery and improve quality of life for patients facing various neurological challenges.
SupplyFrame
Series C in 2009
SupplyFrame is an intelligence platform focused on the global electronics value chain, providing design-to-source intelligence (DSI) solutions that transform how businesses design, source, market, and sell products. The company analyzes billions of signals related to design intent, demand, supply, and risk to deliver valuable insights at critical decision points throughout the product lifecycle. With over 10 million engineering and supply chain professionals utilizing its software-as-a-service (SaaS) solutions, SupplyFrame optimizes more than $120 billion in annual direct materials spending. Headquartered in Pasadena, California, the company has additional offices in various locations including Austin, Belgrade, Grenoble, Oxford, San Francisco, Shanghai, and Shenzhen.
SupplyFrame
Series B in 2007
SupplyFrame is an intelligence platform focused on the global electronics value chain, providing design-to-source intelligence (DSI) solutions that transform how businesses design, source, market, and sell products. The company analyzes billions of signals related to design intent, demand, supply, and risk to deliver valuable insights at critical decision points throughout the product lifecycle. With over 10 million engineering and supply chain professionals utilizing its software-as-a-service (SaaS) solutions, SupplyFrame optimizes more than $120 billion in annual direct materials spending. Headquartered in Pasadena, California, the company has additional offices in various locations including Austin, Belgrade, Grenoble, Oxford, San Francisco, Shanghai, and Shenzhen.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.